Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.58

-0.45

-0.33

-0.2

Details

Expected EPS

-0.20034

Actual EPS

-0.22

Surprise EPS

-0.02

Surprise Percent

+9.81%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.22 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.